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FLICE, A Novel FADD-Homologous ICE/CED-3±like
Protease, Is Recruited to the CD95 (Fas/APO-1)
Death-Inducing Signaling Complex
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execute the apoptotic program is poorly understood.Frank C. Kischkel,²‖ Karen O'Rourke,*‖
It is becoming apparent that cysteine proteases re-Andrej Shevchenko,³‖ Jian Ni,‖§ Carsten Scaffidi,²
lated to the Caenorhabditis elegans cell death geneJames D. Bretz,* Mei Zhang,§ Reiner Gentz,§
ced-3 represent the effector components of the apop-Matthias Mann,³ Peter H. Krammer,²
totic machinery. The first mammalian homolog of CED-3Marcus E. Peter,²# and Vishva M. Dixit*#
identified was interleukin-1b±converting enzyme (ICE;*University of Michigan Medical School
Yuan et al., 1993). Overexpression of ICE or CED-3 inDepartment of Pathology
Rat-1 fibroblasts induced apoptosis, suggesting thatAnn Arbor, Michigan 48109
ICE was functionally, as well as structurally, related to²Tumorimmunology Program
CED-3 (Miura et al., 1993). However, such evidence isGerman Cancer Research Center
only a correlation, as ectopic expression of a numberIm Neuenheimer Feld 280
of proteases, including chymotrypsin, proteinase K, and69120 Heidelberg
trypsin, cause significant apoptosis (Williams and Henk-Federal Republic of Germany
art, 1994).³Protein & Peptide Group
Further studies suggest that proteases related to ICE,European Molecular Biology Laboratory
rather than ICE itself, may play a more important role inMeyerhofstrasse 1
the apoptotic mechanism. First, a number of cell types69012 Heidelberg
stably secrete mature IL-1b without undergoing apop-Federal Republic of Germany
tosis. Second, ICE deficient mice, although unable to§Human Genome Sciences, Incorporated
generate active IL-1b, fail to exhibit a prominent cell9410 Key West Avenue
death±defective phenotype (Kuida et al., 1995; Li et al.,Rockville, Maryland 20850-3338
1995). Third, in an in vitro model of apoptosis, con-
demned phase extracts prepared from chicken DU249
cells fail to cleave the primary substrate of ICE, pro±IL-Summary
1b (Lazebnik et al., 1994). Instead, a proteolytic activity
in these extracts, termed prICE, cleaves the DNA repairTo identify CAP3 and CAP4, components of the CD95
enzyme poly (ADP-ribose) polymerase (PARP) into sig-(Fas/APO-1) death-inducing signaling complex, we
nature apoptotic fragments (Lazebnik et al., 1994). Puri-utilized nano-electrospray tandem mass spectrome-
fied ICE fails to cleave PARP (Lazebnik et al., 1994;try, a recently developed technique to sequence fem-
Tewari et al., 1995), suggesting that prICE is distincttomole quantities of polyacrylamide gel±separated
from ICE.proteins. Interestingly, CAP4 encodes a novel 55 kDa
To date, seven homologs of CED-3 and ICE have beenprotein, designated FLICE, which has homology to
characterized, including Nedd-2/ICH-1 (Kumar et al.,both FADD and the ICE/CED-3 family of cysteine pro-
1994; Wang et al., 1994), Yama/CPP-32/Apopain (Fer-teases. FLICE binds to the death effector domain of
nandes-Alnemri et al., 1994; Nicholson et al., 1995; Tew-FADD and upon overexpression induces apoptosis
ari et al., 1995), Tx/ICH-2/ICE rel-II (Faucheu et al., 1995;that is blocked by the ICE family inhibitors, CrmA and
Kamens et al., 1995; Munday et al., 1995), ICE rel-III
z-VAD-fmk. CAP3 was identified as the FLICE prodo-
(Munday et al., 1995), Mch-2 (Fernandes-Alnemri et al.,
main which likely remains bound to the receptor after
1995a), ICE-LAP3/Mch-3/CMH-1 (Duan et al., 1996a;
proteolytic activation. Taken together, this is unique
Fernandes-Alnemri et al., 1995b; Lippke et al., 1996),
biochemical evidence to link a death receptor physi- and ICE-LAP6 (Duan et al., 1996b). Ectopic expression
cally to the proapoptotic proteases of the ICE/CED-3
of these ICE/CED-3 homologs in a variety of cellscauses
family.
apoptosis. Only Yama and ICE-LAP3 have been shown
to beproteolytically activated by apoptotic stimuli (Chin-
Introduction naiyan et al., 1996a; Duan et al., 1996a; Schlegel et al.,
1996). Future studies will delineate which family mem-
Apoptosis, or programmed cell death, is a genetically bers have an important role in the apoptotic mechanism.
regulated mechanism with a central role in both meta- Although it is clear that CED-3±like proteases are dis-
zoan development and homeostasis (Raff, 1992; Steller, tal effectors of the cell death pathway, the proximal
1995). The celldeath machinery isconserved throughout components that mediate their activation remain to be
evolution (Vaux et al., 1994) and is composed of several identified. Two cell surface cytokine receptors, CD95
distinct parts, including effectors, inhibitors, and activa- (Fas/APO-1) and TNFR-1, have been shown to trigger
tors (Chinnaiyan and Dixit, 1996; Steller, 1995). Inverte- apoptosis by their natural ligands or specific agonist
brate model systems have been invaluable in identifying antibodies (Baglioni, 1992; Itoh et al., 1991; Trauth et
and characterizing the genes that control apoptosis al., 1989). Both death receptors are members of the
(Hengartner, 1996). While numerous candidate genes tumor necrosis factor (TNF)/nerve growth factor recep-
tor family, which also includes TNFR-2, low affinity
NGFR, CD40, and CD30, among others (Smith et al.,‖ The first six authors contributed equally to this manuscript.
#M. E. P. and V. M. D. share senior authorship. 1990; Tewari and Dixit, 1995). While family members
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are defined by the presence of cysteine-rich repeats in electrospray (Fenn et al., 1989), in combination with tan-
dem mass spectrometry (Hunt et al., 1986), was refinedtheirextracellular domains,CD95 and TNFR-1 also share
a region of homology, appropriately designated the to allow sequencing of femtomole quantities of proteins
directly isolated from silver-stained gels (Wilm et al.,ªdeath domain,º required to signal apoptosis (Itoh
and Nagata, 1993; Tartaglia et al., 1993). This shared 1996). The peptide sequence tags (Mann and Wilm,
1994) generated can then be used to screen sequencedeath domain suggests that both receptors interact with
a related set of signal-transducing molecules that, databases to obtain matching sequences leading to iso-
lation of full-length clones for functional characteriza-until recently, remained unidentified. Using the two-
hybrid system, three death domain±containing mole- tion. In its first reported use, an antiangiogenic factor
derived from mycoplasma was characterized using thiscules, TNFR1-associated death domain (TRADD), Fas-
associating protein with death domain (FADD)/MORT1, technique (Wilm et al., 1996).
To identify CAP3 and CAP4, we took advantage of theand receptor-interacting protein (RIP), have been iso-
lated (Boldin et al., 1995; Chinnaiyan et al., 1995; Cleve- above technology of nano-electrospray tandem mass
spectrometry (nano-ES MS/MS). CAP4 is a novel cyste-land and Ihle, 1995; Hsu et al., 1995; Stanger et al.,
1995).Subsequent studies showthat endogenous FADD ine protease of the ICE/CED-3 family that contains a
prodomain homologous to FADD and hastherefore beenassociates with CD95 in an activation-dependent fash-
ion (Kischkel et al., 1995), while, similarly, endogenous designated FLICE (for FADD±like ICE). CAP3 was identi-
fied as the prodomain of FLICE likely generated duringTRADD and RIP have been found complexed to acti-
vated TNFR-1 (Hsu et al., 1996a, 1996b). It has been CD95-induced proteolytic activation. In vitro, the DED
of FADD can directly bind FLICE. Thus, these resultspostulated that TRADD acts as an adaptor molecule for
TNFR-1 (Hsu et al., 1996a), mediating the interaction suggest that CD95 utilizes the adaptor protein FADD
physically to engage FLICE, the apical component of aof TNFR-1 with FADD, while, by contrast, RIP may be
involved in NF-kB signaling (Hsu et al., 1996b). A domi- proteolytic cascade made up of other ICE/CED-3±like
proteases.nant negative version of FADD (FADD-DN) blocks TNF-
and CD95-induced apoptosis, suggesting that FADD
functions as the common signaling conduit for cytokine-
Resultsmediated cell death (Chinnaiyan et al., 1996a; Hsu et
al., 1996a).
Identification of FLICE (CAP4/CAP3)The first evidence for the involvement of ICE±like pro-
At least four endogenous proteins, CAP1±4, associateteases in CD95- and TNFR-1 signaling came with the
with activated CD95 to form the DISC (Kischkel et al.,discovery that the poxvirus gene product CrmA blocks
1995). CAP1 and CAP2 have been identified as differentcell death triggered by both receptors (Enari et al., 1995;
forms of the previously isolated FADD/MORT1 (KischkelLos et al., 1995; Tewari and Dixit, 1995b). In vitro, the
et al., 1995). Subsequent dominant-negative studiesserpin CrmA interacts only with the active forms of ICE
have established that endogenous FADD is essential forand ICE±like proteases (Ray et al., 1992; Tewari et al.,
the recruitment of CAP3 and CAP4 to the CD95 DISC1995). Yama and ICE-LAP3, two of the ICE±like enzymes
(Chinnaiyan et al., 1996a). To identify CAP4, we utilizedmost related to CED-3, are expressed as zymogens that
nano-ES MS/MS (Mann and Wilm, 1995; Wilm and Mann,are proteolytically activated upon ligation of CD95 or
1996) to generate peptide sequence from gel-isolatedTNFR-1 (Chinnaiyan et al., 1996b; Duan et al., 1996a).
protein (Figure 1). The CAP4 spot contained approxi-However, both Yama and ICE-LAP3 remained as pro-
mately 0.5 pmol of protein. The complete sequence ofenzymes in anti-CD95±treated CrmA-expressing cells,
five peptides, covering a total of 41 amino acid residuessuggesting that CrmA inhibits an ICE±like protease up-
and twopartially sequenced peptides that could be usedstreamof Yama and ICE-LAP3 (Chinnaiyan et al., 1996b).
as sequence tags, was determined (Figure 2A). Homol-The mechanism by which the death receptors engage
ogy searches against a comprehensive nonredundantthe cytosolic apoptotic proteases is of central impor-
database (NRDB, maintained by C. Sander, Europeantance to cell death research.
Molecular Biology Laboratory) revealed no matches toActivation of CD95 initiates association with at least
known proteins. However, when the Human Genomefour proteins designated CAP, for cytotoxicity-depen-
Sciences cDNA database was searched, a 3.0 kb cDNAdent APO-1±associated proteins (Kischkel et al., 1995).
was identified and found to contain a 1437 bp openCAP1 and CAP2 have been identified as alternate forms
reading frame that encoded a novel protein with a pre-of serine-phosphorylated FADD, while the identity of the
dicted molecular mass of 55.3 kDa and a pI of 4.91,other CAPs, CAP3 and CAP4, remains to be determined.
consistent with the size and pI of CAP4, as determinedThe four associating proteins, along with the oligo-
by 2D gel analysis (Figures 1A and 1B). The putativemerized receptor, have been termed the CD95 death-
initiator methionine (AAGATGG) was in agreement withinducing signaling complex (DISC; Kischkel et al., 1995).
the consensus Kozak's sequence for translation initia-Later studies demonstrated that a dominant negative
tion. A BLAST search of the GenBank protein databaseversion of FADD, missing the N-terminal death effector
revealed that the novel cDNA, designated FLICE, haddomain (DED), functions by blocking the recruitment of
substantial homology to both FADD and the ICE/CED-3CAP3 and CAP4 to the DISC (Chinnaiyan et al., 1996a).
family of cysteine proteases. CAP3 was also subjectedThus, these results strongly suggest that CAP3 and
to nano-ES MS/MS. Peptides (2) were sequenced, bothCAP4 are downstream components of the CD95 signal-
being identical to two peptides (T2 and T4) found in theing cascade.
Recently, the method of protein sequencing using sequencing of the total tryptic digest of CAP4 (Figure
FLICE Is a Component of the CD95 DISC
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2A). Therefore, CAP3 represents an N-terminal fragment
of FLICE.
FLICE Has Homology to the DED of FADD
The association of CD95 with FADD is mediated by their
respective C-terminal death domains (Boldin et al., 1995;
Chinnaiyan et al., 1995). A truncated derivative of FADD
(FADD-DN), which contains the death domain but lacks
the N-terminus, functions as a potent dominant-nega-
tive regulator of CD95-induced apoptosis (Chinnaiyan
et al., 1996a). By contrast, the 117 N-terminal amino
acids of FADD are capable of triggering apoptosis, and
thus, this segment has been termed the death effector
domain (Chinnaiyan et al., 1995). Interestingly, FLICE
contains two N-terminal stretches of approximately 60
amino acids that are homologous to the DED of FADD
(Figures 2B and 3A). A BLAST search revealed that
residues 7±75 and 101±169 of FLICE matched the DED
of FADD (residues 4±76) and shared 39% identity
(55% similarity) and 28% identity (55% similarity), re-
spectively. Another protein, designated PEA-15, was
also identified as a DED±containing protein by BLAST
search. PEA-15 is an astrocytic phosphoprotein of un-
known function (H. Cheneiweiss, unpublished data;
GenBank accession number S55384).
FLICE Is a Novel Member of the ICE/CED-3 Family
While the N-terminus of FLICE contained the FADD ho-
mology domains, the remainder of the protein was highly
homologous to the ICE/CED-3 family, particularly in the
regions corresponding to the active subunits of ICE (Fig-
ure 3B). Phylogenetic analysis of the ICE/CED-3 gene
family showed that FLICE was a member of the CED-3
subfamily that included Yama/CPP-32, Mch-2, ICE-
LAP3, and ICE-LAP6 (Figure 3C). Like C. elegans CED-3,
FLICE contained a long N-terminal putative prodomain,
but in this case, importantly, the prodomain shared ho-
mology to the DED of FADD. It is likely that CAP3 repre-
sents this prodomain, since its estimated molecular
mass (26 kDa) by 2D gel analysis corresponds exactlyFigure 1. Nano-ES MS/MS Sequence of CAP4
with the calculated molecular massof the putative FLICE(A) Preparation and sequence analysis of CAP4. Silver-stained 2D
prodomain (amino acids 1±220). There was no DED ho-IEF/10% SDS±PAGE of immunoprecipitated DISC from K50 cells.
mology present in any of the other ICE/CED-3 family(B) Autoradiography of an analysis of metabolically labeled DISC
proteins separated on a 2D IEF/10% SDS±PAGE gel. Preparation members.
of the 35S-labeled DISC was done as previously described (Kischkel Based on the X-ray crystal structure of ICE (Walker
et al., 1995). Migration positions of CD95 spots in (A) and (B) are et al., 1994; Wilson et al., 1994), the amino acid residues
labeled by a stippled box. The migration position of CAP4 is indi-
His-237, Gly-238, and Cys-285 of ICE are involved incated by an arrowhead.
catalysis, while the residues Arg-179, Gln-283, and Arg-(C) Part of the mass spectrum of the peptide mixture extracted after
341 form a binding pocket for the carboxylate side chainin-gel digestion of the CAP4 spot with trypsin. Peaks of tryptic
peptides (T1±T7) were sequenced by nano-ES MS/MS. Most of the of the P1aspartic acid. These six residues are conserved
unlabeled peaks are trypsin autolysis products. in all ICE/CED-3 family members thus far cloned as well
(D) Sequencing of peptide number 4 shown in C (m/z 5 626.5) with as in FLICE. However, residues that form the P2±P4
tandem mass spectrometry. Fragmentation of tryptic peptides at
binding pockets are not widely conserved among familythe amide bonds predominantly produced ion series containing the
members, suggesting that they may determine sub-C-terminus (designated Yª1, Yº2, etc.; Roepstorff and Fohlman,
strate specificity. Interestingly, FLICE contained a1984). Half of the tryptic digest was analyzed in this experiment.
(E) Tandem mass spectrum of the same peptide after esterification unique pentapeptide, QACQG, instead of the QACRG
of the second half of the total tryptic digest mixture (Hunt et al.,
1986). Esterification resulted in a characteristic 14 kDa mass shift
of the C-terminus containing the fragment ions (Yª* ions) and an
additional shift of 14 kDa for each Asp and Glu residue. Software- sequencing method, the isobaric amino acids isoleucine and leucine
assisted comparison of the two spectra in (D) and (E) allowed unam- could not be distinguished. For peptides T6 and T7, peptide se-
biguous assignment of peptide sequence. The following sequences quence tags were obtained (Mann and Wilm, 1994) which uniquely
were obtained: T1, LLNDYEEFSKER; T2, FLLQEELSK; T3, QMPQPT identified the peptides VFFIQACQGDNYQK and GIPVETDSEEQPYL
FTLR; T4, FLSLDYLPQR; T5, LLNDYEEFSK. Note that, due to the EMDLSSPQTR, respectively, within the FLICE sequence.
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Figure 2. Sequence Analysis of FLICE
(A) Deduced amino acid sequence of the
FLICE gene product. Sequences (T1±T7) ob-
tained by nano-ES MS/MS are underlined.
Peptide T5 was contained in the sequence of
peptide T1. Peptides T6 and T7 (stippled line)
were peptide sequence tags. The QACQG
conserved pentapeptide containing the cata-
lytic cysteine is indicated in bold.
(B) Schematic model of the FLICE protein.
The N-terminal portion of FLICE (prodomain)
contains two domains that show marked ho-
mology to the N-terminal DED domain of
FADD (shaded boxes). The C-terminus of
FLICE encodes a novel member of the ICE/
CED-3 family of cysteine proteases (filled
boxes). The pentapeptide QACQG is indi-
cated.
shared by most other family members (Figure 3B), with Granzyme B±Activated FLICE Cleaves PARP
the exception of the recently cloned ICE-LAP6, which Members of the ICE/CED-3 gene family are synthesized
contains a QACGG pentapeptide (Duan et al, 1996b). as proenzymes and activated by proteolytic cleavage
at specific aspartate residues to form heterodimeric en-
zymes. In ICE, this cleavage removes the prodomainTissue Distribution of FLICE
and produces a heterodimeric complex consisting ofNorthern blot analysis revealed that FLICE was constitu-
p20 and p10 subunits (Thornberry et al., 1992). Similarly,tively expressed in many fetal and adult human tissues,
activated Yama is comprised of two subunits, p17 andbut not in the fetal brain (Figure 4). Interestingly, there
p12, which are derived from a 32 kDa proenzyme (Nich-was relatively higher expression of FLICE in peripheral
olson, 1996). Recent studies ongranzyme Bsuggest thatblood leukocytes, which was consistent with the impor-
cytotoxic lymphocytes may utilize this secreted serinetant role of CD95-signaling in lymphocyte homeostasis
protease to activate directly members of the ICE/CED-3(Nagata and Golstein, 1995). The mRNA transcript was
family. It has previously been demonstrated that gran-approximately 3.0 kb (Figure 4).
zyme B can proteolytically activate pro-Yama, generat-
ing an active enzyme capable of cleaving the death
FLICE Associates with the DED of FADD
substrate PARP into characteristic fragments (Darmon
Previous studies show that FADD-DN (missing the DED)
et al., 1995; Quan et al., 1996). By contrast, ICE, although
blocks the recruitment of CAP4 to the DISC, suggesting
cleaved by granzyme B, fails to be activated (Quan et
that the DED is an essential component (Chinnaiyan et
al., 1996).al., 1996a). To determine whether FLICE can directly
Thus, we determined whether FLICE could serve asbind FADD and whether the DED of FADD is necessary
a substrate for granzyme B and, more importantly,for this binding, in vitro transcribed and translated FLICE
whether FLICE could function as a cysteine protease.was precipitated with His-6±tagged FADD and His-6±
In vitro transcribed and translated FLICE and Yama weretagged FADD-DN immobilized onto Ni21 beads. As pre-
incubated with purified granzyme B (Hanna et al., 1993).dicted, FLICE bound full-length FADD but not FADD-
After 4 hr at 378C, FLICE and Yama were proteolyticallyDN (Figure 5A). Further confirmation was obtained by
processed, generating putative active p20/p10 andusing 293T cell±generated proteins. In this case, 293T
p17/p12 subunits, respectively (Figure 6A). Next, wecells were transiently transfected with C-terminal±
assessed whether granzyme B±mediated cleavage oftagged FADD-AU1 and DFADD-AU1, in which the 18
FLICE generated an active enzyme by assaying forN-terminal amino acids of the DED were deleted. Cell
PARP cleavage. PARPis proteolyzed during many formslysates were then immunoprecipitated with anti-AU1 an-
of apoptosis, and the enzyme or enzymes responsibletibody and protein G±coupled sepharose. The beads
likely belong to the ICE/CED-3 family (Nicholson et al.,were subsequently incubated with 35S-labeled FLICE or
1995; Tewari et al., 1995). To exclude the possibilityYama/CPP-32, a related ICE/CED-3 family member.
of direct cleavage of PARP by granzyme B, granzymeConsistent with results obtained in Figure 5A, FLICE,
but not Yama, bound full-length FADD (Figure 5B). B±processed FLICE and Yama were incubated with a
FLICE Is a Component of the CD95 DISC
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Figure 3. FLICE Has Homology to Both FADD and ICE/CED3
(A) Two domains contained within the N-terminal portion of FLICE (amino acids 1±34 and 101±132) were aligned with the N-terminus of FADD
and PEA-15. Shading refers to identical residues.
(B) The ICE/CED3 homologous domain of FLICE was aligned with other members of the ICE/CED-3 family. Shading refers to identical residues.
The conserved pentapeptide motif is boxed. Based on the X-ray crystal structure of ICE, conserved residues involved in catalysis are indicated
with filled circles; filled triangles represent the binding pocket for the carboxylate of the P1 Asp; filled squares indicate residues adjacent to
the P2±P4 amino acids.
(C) Phylogenetic analysis of ICE/CED-3 family members.
selective inhibitor of granzyme B (anti-GraB) as pre- Overexpression of FLICE Induces Apoptosis,
Which Is Abrogated by ICE Family Inhibitorsviously described (Quan et al., 1996). Importantly, both
granzyme B±processed Yama and FLICE were active, To study the functional role of FLICE, we transiently
transfected MCF-7 breast carcinoma cells with an ex-as determined by their ability to cleave PARP (Figure
6B). Therefore, unlike ICE, FLICE and other members pression vector encoding the FLICE protein and subse-
quently assessed for apoptotic features. We choseof the CED-3 subfamily are able to cleave PARP into
signature apoptotic fragments (Tewari et al., 1995). MCF-7 cells since they are easily transfectable and are
Cell
822
Figure 5. Specific Interaction of FADD with Radiolabeled FLICE
(A) Interaction of in vitro translated 35S-labeled FLICE and a control
protein, B94, with His-tagged FADD and His-tagged FADD-DN im-
mobilized onto Ni21 beads. After the beads were washed, retained
bound FLICE or B94 proteins were analyzed by SDS±PAGE and
autoradiography. The same amount of 35S-labeled proteins used for
the binding assay (input) was loaded directly onto the gel as a
control. The gel was stained with Coomassie blue prior to autoradi-
ography to confirm equivalent amounts of His-tagged FADD and
FADD-DN in each lane (data not shown).Figure 4. FLICE Is Expressed in a Variety of Tissues and Develop-
(B) Interaction of 35S-labeled FLICE or Yama with FADD-AU1 ormental Stages
DFADD-AU1 lacking only 18 N-terminal residues. 293T cells were
A human adult and fetal tissue poly(A1) Northern blot (Clontech) transfected with AU1 epitope-tagged FADD or AU1 epitope-tagged
was probed with 32P-labeled FLICE cDNA. PBL, peripheral blood
DFADD and the cleared lysates immunoprecipitated with anti-AU1
leukocytes. antibody and protein G±coupled Sepharose. Following incubation
with in vitro translated 35S-labeled FLICE or Yama, the beads were
washed and retained FLICE or Yama detected by SDS±PAGE and
sensitive to CD95-induced killing (Tewari and Dixit, autoradiography. The presence of equivalent amounts of FADD-
AU1 and DFADD-AU1 in the immune complex was assessed by1995b). Like the other ICE/CED-3 family members, over-
immunoblotting using a specific rabbit antiserum raised againstexpression of FLICE caused apoptosis (Figure 7). The
FADD (data not shown).FLICE±transfected cells displayed morphological alter-
ations typical of adherent cells undergoing apoptosis,
becoming rounded, condensed, and detaching from the
fibroblast proliferation, resistance to intracellular patho-dish (data not shown). FLICE±induced cell death was
gens including chlamidiae, and synthesis of prostaglan-inhibited by the broad spectrum ICE inhibitor z-VAD-
din E2 (Tartaglia and Goeddel, 1992). Likewise, TNFR-1fmk (Fearnhead et al., 1995; Pronk et al., 1996; Figure
recruits a multivalent adaptor molecule termed TRADD,7), which is also a potent inhibitor of CD95-induced
which, like FADD, contains a death domain required forapoptosis (A. M. C., unpublished data). Like the peptide
receptor association (Hsu et al., 1995). TRADD has beenICE family inhibitor, CrmA blocked FLICE±induced cell
shown to bind a number of signaling molecules, includ-death (Figure 7), suggesting that FLICE may be a physio-
ing FADD, TNFR-associated protein 2, and RIP (Hsu etlogic target for this poxvirus serpin. Alternatively, FLICE
al., 1996a, 1996b). A dominant-negative version of FADDmay activate a downstream CrmA-sensitive protease.
blocks TNF killing (Chinnaiyan et al., 1996a; Hsu et al.,
1996a), while dominant-negative versions of TNFR-as-Discussion
sociated protein 2 and RIP block TNF±induced NF-kB
activation (Hsu et al., 1996a, 1996b). This indicates theThe Physical Link Between Death Receptors
existence of a signaling bifurcation dictated by the na-and Apoptotic Proteases
ture of the associated adaptor molecules. Regardless,Prior to this study, the link between activators and ef-
TNFR-1 indirectly uses FADD toengage the death prote-fectors of the cell death machinery was unclear. Here we
ase FLICE and thereby unites the death pathways thatdemonstrate that a cell-surface death receptor (CD95)
emanate from CD95 and TNFR-1.uses an adaptor molecule (FADD) to engage physically
Emphasizing the evolutionary conservation of thea cytosolic apoptotic protease termed FLICE. The death
apoptotic machinery, the Drosophila death proteindomain is an important signaling motif shared by both
Reaper shares weak homology to the death-domain mo-CD95 and TNFR-1, and oligomerization of this domain
tif (Golstein et al., 1995) and, like CD95 and TNFR-1, isrecruits cytosolic adaptor proteins to assemble a signal-
capable of initiating the apoptotic program (White et al.,ing complex (DISC; Peter et al., 1996). The assembly of
1994, 1996). Reaper mediates its actions by activatinga DISC is essential for CD95 signal transduction. Upon
ICE/CED-3±like proteases as both z-VAD-fmk and theactivation, the death domain of the receptor binds to the
baculovirus ICE family inhibitor p35 block Reaper-in-death domain of the adaptor molecule FADD (CAP1, -2)
duced cell death (Pronk et al., 1996; White et al., 1996).and thereby recruits it to form part of the DISC. The
Given our dataon death-domain receptors, it is temptingcomplete DISC is created when FADD, in turn, binds
to speculate that Reaper mayexert its actions by directlyand recruits the ICE/CED-3±like protease FLICE (CAP4).
or indirectly engaging ICE/CED-3±like proteases in aWhile the main activity of CD95 is to trigger cell death,
TNFR-1 can signal a diverse range of activities, including manner analogous to FADD and CD95, respectively.
FLICE Is a Component of the CD95 DISC
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Figure 7. FLICE±Induced Apoptosis IsBlocked by ICE/CED-3 Inhib-
itors z-VAD-fmk and CrmA
Previously characterized MCF-7 clonal lines (Tewari et al., 1995a)
were transiently transfected with pCMV-b-galactosidase in the pres-
ence of a two-fold excess of vector alone or expression constructs
encoding FADD or FLICE. The broad spectrum ICE family inhibitor
z-VAD-fmk (20 mM) was added to the cells 5 hr posttransfection.
Cells were fixed and stained for b-Gal expression 42 hr following
transfection. The data (mean plus or minus standard error of the
mean) shown are the percentage of round blue cells as a function
of the total number of blue cells counted (n 5 3).
Importantly, the Asp-specificproapoptotic serine pro-
tease granzyme B proteolytically activates FLICE in aFigure 6. Granzyme B±Processed FLICE Is an Active Protease That
manner similar to Yama/CPP-32 (Darmon et al., 1995;Cleaves PARP to the Signature 85 kDa Apoptotic Fragment
Quan et al., 1996). By contrast, ICE is processed, but(A) Processing of FLICE and Yama by granzyme B (GraB) in vitro.
not activated, by granzyme B (Quan et al., 1996). Secre-35S-labeled FLICE and Yama were incubated with purified GraB for
4 hr and the reaction products analyzed by SDS±PAGE and autoradi- tion of granzyme B, in combination with the pore-form-
ography. The active subunits of Yama (p17/p12) and FLICE (p20/ ing protein perforin, is one of two mechanisms by which
p10) are indicated. A 27 kDa species of FLICE was also generated cytotoxic T lymphocytes trigger apoptosis of suscepti-
by granzyme B, likely representing the FLICE prodomain.
ble target cells, the other being engagement of CD95(B) GraB-processed FLICE and Yama cleave PARP. Following GraB
on the target cell surface (Berke, 1995). Thus, granzymeprocessing, anti-GraB, a specific GraB inhibitor, was added and
B likely mediates apoptosis by directly activating theproteolytically processed FLICE or Yama assessed for activation
by incubating with the putative substrate PARP. No cleavage was death effector machinery of the target cell, which is
detectable when PARP was incubated alone (control) or with the composed of an arsenal of intracellular CED-3±like cys-
zymogen-unprocessed form of FLICE. PARP was detected by immu- teine proteases. FLICE and other members of the CED-3
noblotting using a specific anti-PARP antibody.
subfamily (K. Orth and A. M. C., unpublished data) are
almost certainly activated during both granzyme B± and
CD95-mediated apoptosis, suggesting the convergenceFLICE Is Homologous to FADD and Is a Cysteine
of distinct apoptotic pathways involved in cell-mediatedProtease of the ICE/CED-3 Family
immunity.FLICE is an intriguing molecule with homology to both
FADD and the ICE/CED-3 family. The prodomain of
FLICE is homologous to the DED of FADD, which is a Identity of CAP3
CAP3 likely represents the N-terminal prodomain ofcritical motif required for engaging the death pathway.
Phylogenetic comparison of FLICE with other ICE/ FLICE, consistent with the finding that the predicted
molecular mass and pI of the N-terminal 220 amino acidsCED-3 family members classify this cysteine protease
in the CED-3 subfamily along with Yama/CPP-32, ICE- of FLICE correspond to CAP3. Like CAP4, CAP3 was
only found to be associated with the activated CD95LAP3, ICE-LAP6, and Mch-2 (Figure 3C). FLICE clearly
represents the most upstream enzymatic activity in the receptor requiring full-length FADD for binding (Chinnai-
yan et al., 1996a). It is conceivable that CAP3 is gener-CD95 pathway, and itwill thus be important to determine
which ICE/CED-3 family members are proteolytically ac- ated by proteolytic activation of FLICE during CD95 liga-
tion but retained in the DISC by virtue of its ability stilltivated by FLICE, leading to amplification of the death
signal. Though activated FLICE cleaves PARP well (Fig- to bind the DED of FADD. The active dimeric p20/p10
subunits of FLICE are likely liberated from the DISC andure 6), this is unlikely to be the physiologic substrate
for FLICE and was only used as a readout to monitor are free to cleave and activate downstream apoptotic
proteases. If this scenario is correct, CAP4 representsthe generation of proteolytically competent FLICE by
granzyme B (Figure 6). Physiologic PARP cleavage is the inactive zymogen form of FLICE, which during CD95
signaling gets activated, generating a free active hetero-more likely mediated by the downstream enzymes Yama
and ICE-LAP3 (Fernandes-Alnemri et al., 1995; Lippke dimeric enzyme and a prodomain that is still retained
by the DISC (CAP3).et al., 1996; Nicholson et al., 1995; Tewari et al., 1995).
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min with 50 ml lysis buffer (20 mM Tris±HCl [pH 7.4], 140 mM NaCl,How Is FLICE Activated?
10% [w/v] glycerol, 1% [v/v] Triton X-100, 2 mM EDTA, 1 mM phenyl-Taken together, our data enable us to propose an intri-
methylsulfonyl fluoride, and 1 mg/ml of the following peptide inhibi-guing model for FLICE activation. In the latent state, the
tors: antipain, chymostatin, leupeptin, and pepstatin A). After two
two DEDs of FLICE may bind to each other, preventing centrifugations for 15 min at 14,000 rpm, the supernatant was pre-
FLICE activation. CD95 stimulation and resultant trimeri- cleared with 400 mg of the isotype-matched control antibody FII23c
(Kischkel et al., 1995) coupled to 400 ml of CNBr±activated Sepha-zation causes binding of FADD. This may trigger a con-
rose CL-4B (Pharmacia) for 12 hr. The DISC was thenimmunoprecip-formational change in the DED of FADD, allowing it to
itated with 200 ml of a 50% suspension of PA-Sepharose (Phar-bind one of the corresponding DEDs of FLICE. By dis-
macia). After 12 hr, the beads were washed five times with lysisrupting the self-association of the FLICE DEDs, the ICE/
buffer and the bound proteins solubilized in IEF sample buffer, then
CED-3 homology domain of FLICE may be free to un- subjected to IEF essentially as described (Peter et al., 1995). The
dergo autocatalytic activation. The active p20/p10 pro- IEF sample buffer contained 9.8 M urea, 4% (w/v) NP-40, 2% (v/v)
ampholines (pH 7.9; Pharmacia) and 100 mM dithiothreitol. The tubetease is liberated from the DISC and subsequently ig-
gel used for the first dimension was 25 cm long and had an internalnites a proteolytic cascade composed of other ICE/
diameter of 2.5 mm. The IEF gel was run at 1200 V for 20 hr. ForCED-3 family members. The FLICE prodomain (CAP3)
the second dimension, a 200 3 1 mm 10% SDS±PAGE gel wasremains bound to the receptor.
used. Protein spots were visualized by silver staining as described
(Shevchenko et al., 1996). The identities of silver-stained CAP3 and
Nano-ES MS/MS as a Technique to Identify CAP4 with the respective 35S-labeled CAP4 spot described recently
(Kischkel et al., 1995) was confirmed in a parallel experiment inProtein Interaction Partners
which unlabeled and labeled protein were separated on the sameThe cloning of FLICE represents a unique instance of a
gel, which was first silver-stained, then dried and subjected to auto-protein being identified by direct sequencing of a silver-
radiography.
stained spot (containing protein in the femtomole range)
from a 2D isolectric focusing (IEF)/SDS±polyacrylamide Sequencing of CAP3 and CAP4 with Nano-ES MS/MS
gel electrophoresis (SDS±PAGE) gel by nano-ES MS/ The silver-stained CAP3 and CAP4 spots were cut out and in-gel±
MS. The exceptional sensitivity of this technique opens digested with trypsin, followed by a single purification and concen-
tration step as previously described (Shevchenko et al., 1996; Wilmup new experimental vistas. Just as it did in this report,
et al., 1996). The recovered unseparated peptide mixtures wereitwill allow investigators to analyze endogenous compo-
sequenced on a triple quadrupole mass spectrometer API III (Sciex)nents of signaling complexes, confirming and extending
equipped with a nano-electrospray ion source (Wilm and Mann,
findings obtained from the application of techniques 1996).
such as the two-hybrid system, which, in particular, is
plagued by false positive interactions. Additionally, cDNA Cloning
The sequence obtained from the characterized peptides was usednano-ES MS/MS can be used to identify proteolytic
to screen the Human Genome Sciences private database usingcleavage products (such as in the case of CAP3) and
established expressed-sequence-tag methods. A clone designatedsites of posttranslational modifications including phos-
HHFHY89 was identified and subjected to both automated and man-
phorylation. As more cDNA sequences accumulate, the ual sequencing. Additionally, a random-primed cDNA library con-
technique should become generally applicable to most structed in the pcDNA1 vector (Invitrogen) from human umbilical
human gene products. vein endothelial cell poly(A)1 RNA was screened with a 32P-labeled
BamHI±XhoI restriction fragment of the HHFHY89 clone (Sambrook,
1989). DNA sequence analysis of hybridizing clones confirmed theConclusions
original sequence.The CD95-mediated apoptotic cascade is initiated by
the direct physical association of the death receptor Northern Blot Analysis
CD95 with the adaptor molecule FADD and the effector Adult and fetal human multiple tissue Northern blots (Clontech) were
protease FLICE, a novel member of the ICE/CED-3 fam- hybridized according to instructions of the manufacturer, using a
radiolabeled cDNA insert obtained from a BamHI±XhoI digestion ofily. The assembly of this signaling complex occurs in a
the HHFHY89 plasmid.hierarchical manner upon receptor activation. The death
domain of the receptor binds to the death domain of
Expression Vectorsthe adaptor molecule FADD, which, in a manner that
FLICE cDNA encoding the entire open reading frame was generated
remains to be determined, binds and activates FLICE by polymerase chain reaction and subcloned into the mammalian
to generate the most apical enzymatic component of a expression vector pcDNA3 (Invitrogen).
His-tagged FADD and His-tagged FADD-DN were obtained usingdeath cascade composed of other ICE/CED-3 family
custom polymerase chain reaction primers encoding the epitopemembers. The essential components of an apoptotic
and FADD cDNA as template. The amplified products were sub-cascade have here been elucidated. The mode of as-
cloned into the prokaryotic pET vector system (Novagen). FADD-sembly of the DISC and the mechanism by which FLICE
AU1 and the truncated form of FADD lacking 18 N-terminal amino
is activated will be critical questions for future investi- acids (designated DFADD-AU1) were similarly generated using cus-
gation. tom polymerase chain reaction primers encoding the epitope and
FADD cDNA as template. Polymerase chain reaction products were
subcloned into the KpnI±XhoI sites in the pcDNA3 expression vector.Experimental Procedures
Preparation of CAP3 and CAP4 for Sequencing In Vitro Binding Assay
His-tagged FADD and His-tagged FADD-DN proteins were ex-The human full-length CD95 transfectant K50 (Oehm et al., 1992)
was cultured in 5 l of RPMI with 10% fetal calf serum, 10 mM HEPES pressed, purified, and immobilized onto Ni21 beads according to
standard methodology.(pH 7.3), 100 mg/ml Gentamycin to a density of 2.8 3 106 cells/ml.
Cells (1.4 3 1010) were then stimulated in 100 ml medium with 10 35 S-labeled FLICE, Yama, and B94 proteins were prepared by in
vitro transcription or translation using the TNT T7±coupled reticulo-mg/ml anti±APO-1 (IgG 3) for 10 min at 378C. After washing once
with phosphate-buffered saline, the cells were lysed on ice for 30 cyte lysate system (Promega) according to the instructions of the
FLICE Is a Component of the CD95 DISC
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